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Abstract
Nav1.6 and Nav1.6 mediated resurgent currents have been implicated in several pain pathologies. 
However, our knowledge of how fast resurgent currents are modulated in neurons is limited. Our 
study explored the potential regulation of Nav1.6 mediated resurgent currents by isoforms of 
Fibroblast growth Factor Homologous factor 2 (FHF2) in an effort to address the gap in our 
knowledge. FHF2 isoforms colocalize with Nav1.6 in peripheral sensory neurons. Cell line studies 
suggest that these proteins differentially regulate inactivation. In particular, FHF2A mediates long-
term inactivation, a mechanism proposed to compete with the open-channel blocker mechanism 
that mediates resurgent currents. On the other hand, FHF2B lacks the ability to mediate long-term 
inactivation and may delay inactivation favoring open-channel block. Based on these observations, 
we hypothesized that FHF2A limits resurgent currents, whereas, FHF2B enhances resurgent 
currents. Overall our results suggest that FHF2A negatively regulates fast resurgent current by 
enhancing long-term inactivation and delaying recovery. In contrast FHF2B positively regulated 
resurgent current and did not alter long-term inactivation. Chimeric constructs of FHF2A and 
Navβ4 (likely the endogenous open channel blocker in sensory neurons) exhibited differential 
effects on resurgent currents suggesting that specific regions within FHF2A and Navβ4 have 
important regulatory functions. Our data also indicate FHFAs and FHF2B isoform expression are 
differentially regulated in a radicular pain model and that associated neuronal hyperexcitability is 
substantially attenuated by a FHFA peptide. As such, these findings suggest that FHF2A and 
FHF2B regulate resurgent current in sensory neurons and may contribute to hyperexcitability 
associated with some pain pathologies.
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INTRODUCTION
Voltage gated sodium channels (VGSC) selectively mediate the inward flow of sodium ions 
generating the rapid upstroke of the action potential (26, 41). As such alteration of sodium 
channel activity can be an underlying mechanism in neurological pathologies (31) including 
but not limited to pain (8, 10, 12, 61). Painful sensations can commonly arise from increased 
firing of peripheral sensory neurons in Dorsal Root Ganglia (DRG) and Trigeminal Ganglia 
(49). Adult DRG neurons normally express a variety of VGSC isoforms that can be 
distinguished based on their sensitivity to tetrodotoxin (TTX) inhibition resulting in two 
classes: TTX-Sensitive (TTXS: Nav1.1, 1.6, Nav1.7) and TTX-Resistant (TTXR: Nav1.8 
and Nav1.9) channels (4, 13–15, 25). Some of these VGSC isoforms can generate an 
unusual current known as resurgent current (6, 22, 28, 44, 55). Resurgent currents are 
generated when VGSCs open (upon membrane depolarization) and an open channel blocker 
out-competes the intrinsic mechanism of inactivation (fast inactivation) and blocks the 
channels in the open conformation (1, 21, 34). This open channel block mechanism 
temporarily terminates further sodium influx because as the membrane repolarizes the 
blocker unbinds and sodium influx resurges (46). Thus, resurgent currents generate a 
depolarizing drive during membrane repolarization that may enable the generation of 
another action potential (47). In this manner, resurgent currents contribute to increased 
neuronal activity.
Two types of resurgent currents have been identified in DRG neurons based on their 
kinetics: fast and slow. Under normal conditions, Nav1.6 predominantly mediates fast 
resurgent currents (6), whereas Nav1.8 mainly mediates slow resurgent currents (55). In this 
study we investigate how fast resurgent currents are modulated in DRG neurons. There is a 
breadth of evidence that implicates fast resurgent currents in increased neuronal activity and 
pain pathologies such as: radicular pain (71), oxaliplatin acute painful neuropathy (53), 
ATX-II induced pain (29), and Paroxysmal Extreme Pain Disorder (28, 56). Interestingly, 
recent studies using animal models of inflammatory, neuropathic and chemotherapeutic 
induced pain suggest Nav1.6 has an important role in mediating painful sensations (9, 38, 
52, 53, 68, 70). Together these findings suggest targeting Nav1.6 mediated activity, such as 
resurgent currents, may provide novel strategies for pain therapeutics. However, our 
understanding of how fast resurgent currents are modulated in DRG neurons is fairly 
limited. Sodium channel auxiliary subunits are potential candidates for resurgent current 
modulation. For example, we recently reported that sodium channel beta 4 subunit (Navβ4) 
is a major determinant of resurgent currents in DRG neurons (3). Our results were consistent 
with Central Nervous System (CNS) studies, which proposed the C-terminal sequence of 
this subunit acts as an open channel blocker (2, 21, 39). In particular, a region of 20 amino 
acids within the cytoplasmic C-terminal region (known as the β4 peptide) is predicted to be 
key for Navβ4 positive regulation of fast resurgent currents (57, 75). Inclusion of the β4 
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peptide in cell lines and neurons that do not endogenously generate resurgent currents 
evokes them (42, 51). Similar effects are observed in DRG neurons, where inclusion of the 
β4 peptide or expression of the full length Navβ4 protein evokes and enhances resurgent 
currents (64). In contrast, overexpression of a mutant form of Navβ4 in which key residues 
within the β4 peptide region were neutralized reduced resurgent current generation further 
confirming the importance of this region for resurgent current generation.
Fibroblast Growth Factor Homologous Factors (FHF1–4 also known as FGF11–14) are 
another family of auxiliary proteins that recent studies suggest regulate resurgent currents in 
CNS neurons (57, 75). Contrary to their homologue counterpart, FHFs are not secreted and 
function independent of fibroblast growth factor receptors (42, 51). Thus, FHFs are 
intracellular signaling proteins that have multiple interacting partners including microtubules 
(64), kinases (62), scaffolding proteins (50, 51), nuclear factors (30), calcium channels (74) 
and VGSCs (19, 77). FHF interaction with VGSC can alter the biophysical properties of 
activation, inactivation and current density (19, 43). Adult DRG neurons can express a 
variety of FHF isoforms including FHF1, FHF2 and FHF4 (27, 35, 48, 63, 77). Each FHF 
gene can result in different isoforms through alternative splicing and promoter usage 
resulting in distinct N-terminal sequences (40). “A” and “B” isoforms have conserved core 
domains that enable them to bind to the C-terminus of sodium channels (18, 36, 58, 60).
FHF “A” isoforms have two distinct features: 1) a long N-terminal sequence and 2) a 
bipartite nuclear localization signal (NLS), which may be active or inactive depending on the 
cell background (54). FHFAs unique N-terminus expresses a peptide sequence (which is 
highly conserved between all FHFAs) that may interact with VGSC channels and induce 
long-term inactivation (16). This long-term inactivation particle competes with the intrinsic 
mechanism of inactivation (fast inactivation). Open channel block, which mediates resurgent 
currents, also competes with fast inactivation (34). Based on these observations, Goldfarb et 
al. (2012) proposed that long-term inactivation might compete with open-channel block (20). 
In a Nav1.5 cell line addition of long-term inactivation peptide reduced β4-peptide mediated 
resurgent currents supporting the possibility that these particles compete with each other 
(57). In contrast, FHF “B” isoforms do not mediate long-term inactivation but may alter 
voltage dependence and kinetics of inactivation in ways that likely favor open channel block 
(19). For example FHF4B in Purkinje neurons increased resurgent currents by slowing the 
rate of inactivation and shifting the voltage dependence of inactivation to positive potentials 
increasing the probability of binding for the endogenous open channel blocker (75). It is 
important to note that not all FHF isoforms are reported to have the same effect with all 
VGSC isoforms. For Nav1.6, heterologous co-expression of FHF2 and FHF4 isoforms 
consistently caused a shift in the voltage dependence of inactivation to positive potentials, 
whereas, differential effects were observed in current density depending on VGSC isoform 
and cell background. In ND7/23 cells FHF2 isoforms exhibited differential effects in 
response to trains of stimulation. FHF2A caused accumulation of inactivation at all 
frequencies due slowing recovery from inactivation, whereas, FHF2B protected the channel 
from inactivation at high frequencies with no change in recovery (48, 63). In this study, we 
investigate the role of FHF2 isoforms (also known as FGF13) in regulating fast resurgent 
currents because they have been shown to co-localize with Nav1.6 (the main carrier of fast 
resurgent current) in DRG neurons. Therefore we hypothesized that FHF2A inhibits fast 
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resurgent currents in sensory neurons through long-term inactivation. In contrast, FHF2B 
lacks the ability to mediate long-term inactivation and may alter inactivation favoring open 
channel block similar. Therefore, we hypothesized that FHF2B increase resurgent currents 
by delaying inactivation.
Our results show that FHF2A negatively regulates resurgent currents and enhances long-
term inactivation, whereas, FHF2B positively regulates resurgent currents and does not alter 
long-term inactivation. Data obtained from chimeric constructs of FHF2A and Navβ4 
provided insight into the importance of FHF2A’s long-term inactivation particle and the 
Navβ4 open channel blocker sequence for the direction (positive versus negative) of 
resurgent current modulation. In neurons harvested from animals with localized 
inflammation of the DRG, we observed reduced FHFAs’ expression whereas FHF2B’s 
expression was enhanced. Our findings suggest that this differential modulation of FHF2A 
and FHF2B could contribute to enhanced resurgent currents and result in sensory neuron 
hyperexcitability. Interestingly, neuron hyperexcitability associated with localized 
inflammation of the DRG was substantially reduced by FHFA peptides that induce long-
term inactivation. Overall our data indicate that FHFs are important regulators of VGSC 
activity in sensory neurons and suggest that alterations in FHF2A and FHF2B expression 
likely contribute to changes in nociception and pain.
METHODS
cDNA constructs
These studies used cDNA constructs of sodium channel auxiliary subunits, FHF2A, FHF2B 
and chimeric constructs of FHF2A and Navβ4. All constructs were tagged at the C-terminus 
with photostable monomeric Turquoise2 (pmTurquoise2) to verify expression. To generate 
the FHF2A and FHF2B tagged constructs, the coding sequence corresponding to mouse 
FHF2A (NP_034330.2) and human FHF2B (NP_378668.1) were synthesized and purchased 
from Genscript (Piscataway, NJ). Mouse FHF2A protein is 99.56% identical to human 
FHF2A (NP_004105.1) and is predicted to be 100% identical to rat FHF2A (NC_005120.4). 
Human FHF2B protein is 99.48% identical to mouse (NP_001277344.1) and rat FHF2B 
(NP_445880.1). The FHF2A sequence was cut from a pUC57 vector and inserted into 
pmTurquoise2-N1 vector with HindIII/KpnI restriction enzymes. The FHF2B sequence was 
cut from pcDNA3.1 (+) vector and inserted into pmTurquoise2-N1 vector with HindIII/
BamHI restriction enzymes. The sequences were moved in-frame by site directed 
mutagenesis (Quikchange XL II Site Directed Mutagenesis kit, Agilent Technologies).
The chimeric constructs of FHF2A and Navβ4 were designed in-house by replacing the 
long-term inactivation particle sequence (AAAIASSLIRQKRQAREREK, 20 amino acids 
(16)) with the Navβ4 open-channel blocker sequence (KKLITFILKKTREKKKECLV, 20 
amino acids (33)) to generate the F2A(β4) construct. Conversely, the open channel sequence 
in rat Navβ4 (NP_001008880.1) was replaced with the long-term inactivation particle of 
FHF2A to generate the (β4)F2A construct. The full chimeric sequences were synthetically 
made and purchased from Genscript (Piscataway, NJ). The F2A(β4) and (β4)F2A sequences 
were cut from the pUC57 vector and sub-cloned into pmTurquoise-N1 with NheI/XhoI 
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restriction enzymes. To move the sequences in frame with the fluorescent protein the stop 
codon was mutated to a glycine residue using site-directed mutagenesis.
To study Nav1.6 in isolation from endogenous TTXS channels we used a Nav1.6 TTXR 
construct previously described in (44). Briefly, the sequence corresponding to human Nav1.6 
protein (NP_055006.1) was codon-optimized and purchased from Genscript (Piscataway, 
NJ). The sequence was then sub-cloned into pcDNA3.1 (+) with KpnI/XbaI restriction 
enzymes. The Nav1.6 sequence was then modified with site directed mutagenesis to confer 
high resistance to TTX by converting tyrosine residue 371 to serine as previously described 
(24, 32). The resulting construct was named Nav1.6r. Additionally, we knocked down 
endogenous TTXR Nav1.8 channels with a small hairpin RNA (shRNA) plasmid to aid in 
the isolation of Nav1.6r currents. The Nav1.8 shRNA-IRES-dsRED plasmid encoded for 
Nav1.8 shRNA sequence (targeting sequence, GATGAGGTCGCTGCTAAG, (37) and an 
internal ribosome entry site for the translation of fluorescent protein marker dsRed (IRES-
dsRED) as previously described (3, 28).
Cell culture
DRG neurons were obtained from adult male Sprague Dawley rats. Rats were euthanized by 
CO2 exposure and secondary decapitation. The spinal column was then removed and DRG 
were harvested from the lumbar to cervical region. The nerve processes were cut from the 
excised ganglia. Ganglia were then digested in Dulbecco’ modified Eagle’s Medium 
(DMEM, Fisher Scientific) containing collagenase (1.25 mg/mL) and neutral protease (0.78 
mg/mL) for 45 minutes at 37 °C. Subsequently, the digested ganglia were centrifuged at 
1000rpm for five minutes. Digestion media was aspirated and replaced with 10% Fetal 
Bovine Serum (FBS, Hyclone) DMEM (Invitrogen) and ganglia were mechanically 
triturated with sequentially smaller glass pipettes. Triturated ganglia were spun again at 700 
rpm for five minutes. Media was aspirated and replaced with fresh 10% FBS DMEM media. 
Aliquots of cell suspension (~100uL) were loaded unto glass coverslips coated with poly-D-
lysine and laminin. After 10 minutes, cells settled and 500uL of 10% FBS DMEM was 
added to each well. For electrophysiological experiments with transfected neurons, the 10% 
FBS DMEM media was supplemented with mitotic inhibitors, 5-fluoro-2-deoxyuridine 
(50uM, Sigma Aldrich) and uridine (150uM, Sigma Aldrich), to prevent overgrowth of the 
supporting cells. Dissociated cultures were maintained at 37°C in a humidified 95% air and 
5% CO2 incubator. Media was changed every two days.
For Localized Inflammation of the DRG (LID) experiments, L4 and L5 ipsilateral DRG 
were excised from sham operated rats and inflammation induced rats at post-operative day 5. 
The above dissociation protocol and culture was followed with the exception of the digestion 
time, which was decreased to 28 minutes. Indiana University School of Medicine 
Institutional Animal Care and Use Committee approved the animal protocols described 
above.
Surgical procedure for localized inflammation of the DRG
Localized inflammation of the DRG was used as a model of radicular pain as previously 
discussed in (76) and described in (66). Adult male Sprague Dawley rats under isoflurane 
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anesthesia were used for these procedures. After deep anesthesia was verified, an initial 
incision on the back near the spinal column was made from L3–S1 to expose and visualize 
the superficial area of the spine. Then, a second deeper incision was made on one side of the 
animal approximately 1mm from the center of the spine from L4 to S1. Paraspinal muscles 
near L4/L5 were carefully teased apart until intervertebral foramen could be visualized using 
the transverse processes, ilium and dorsal/ventral ramus as guides. Aliquots of 10uL 
containing zymosan diluted in incomplete Freud Adjuvant (2mg/mL) were injected above 
L4 and L5 DRG, through a needle inserted close to the DRG through the intervertebral 
foramen. The needle was bent in a 90 degree angle ~2 mm from the tip for easier access and 
was left for two minutes after injection to prevent leakage. After injection, the area was 
sutured by layers. Sham operated animals were used as a control; the above procedure was 
followed with the exception of zymosan injection. Indiana University School of Medicine 
and University of Cincinnati Institutional Animal Care and Use Committees approved the 
surgical procedure described.
Behavioral measurements
Mechanical sensitivity was tested by applying a series of von Frey filaments to the heel 
region of the paws on animals with L5 localized inflammation, using the up-and-down 
method (5). A cutoff value of 15 grams was assigned to animals that did not respond to the 
highest filament strength used. A fine wisp of cotton was stroked mediolaterally across the 
plantar surface of the hindpaws to score the presence or absence of a brisk withdrawal 
response to a normally innocuous mechanical stimulus (light touch-evoked tactile allodynia). 
This stimulus does not evoke a response in normal animals. Cold sensitivity (cold allodynia) 
was scored as withdrawal responses to a drop of acetone applied to the ventral surface of the 
hind paw. When observed, responses to acetone or light brush strokes consisted of several 
rapid flicks of the paw and/or licking and shaking of the paw; walking movements were not 
scored as positive responses. Hypersensitivity to thermal (heat) stimuli was not examined 
because we have previously observed that this is little affected by LID (72). The tester was 
blinded as to the sham or LID status of the animals. All data presented are from the 
ipsilateral side; in this model the contralateral side shows little or no hypersensitivity in any 
of the tests used (data not shown). Behavioral time course data were analyzed using two-way 
repeated measures ANOVA with Bonferroni post hoc test to determine on which days 
experimental groups differed. The experimental protocol was approved by the Institutional 
Animal Care and Use Committee of the University of Cincinnati.
Immunocytochemistry
To study the expression pattern of FHF2A and FHF2B after inflammation, L4 and L5 
ipsilateral DRG ganglia were harvested and cultured from sham operated and inflammation 
induced animals at post-operative day 5. DRG neurons were fixed after 24 hours in culture, 
permeabilized, blocked and treated with antibodies in the following manner: Cells were 
fixed with 4% paraformaldehyde (0.1 M phosphate buffer, pH 7.4) for 20 min at room 
temperature, washed with phosphate buffered saline (PBS), permeabilized in 1% Triton 
X-100 in PBS for 20 min at room temperature, washed with PBS, blocked for 2 h (10% 
normal goat serum, 0.1% Triton X-100 in PBS) at room temperature, washed with PBS, 
incubated in primary antibodies diluted in blocking solution overnight at 4°C, washed with 
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PBS and incubated with secondary antibody in blocking solution for 2 h at room 
temperature. Primary antibodies used were Anti-Pan-FHF-A (1:200, Clone N235/22, UC 
Davis/NIH NeuroMab Facility) and monoclonal Anti-FGF13/FHF2.B (1:200, Clone 
N225A/10, UC Davis/NIH NeuroMab Facility). Secondary antibody used was Alexa Fluor® 
488 Goat Anti-Mouse IgG (Molecular Probes, Life Technologies) at 1:750 concentration. 
Coverslips were mounted unto microscope slides with Prolong Gold Antifade (Molecular 
Probes). DRG neurons were imaged using Axio Observer Z1 Widefield Microscope with a 
20X objective (ZEISS Microscopy). Images were analyzed using NIS Elements Advance 
Research (Nikon®) software by defining each cell as a region of interest and quantifying the 
mean intensity signal for FHF2A and FHF2B. The mean intensity signal was compared 
between sham and LID groups using Student’s t-test. Quantification experiments were 
carried out independently at least five times; more than 1000 cells were counted for each 
condition.
Recombinant Expression in DRG neurons
DRG neurons were transiently co-transfected with Nav1.6r, tagged auxiliary subunit and 
Nav1.8 shRNA-IRES-dsRED using the Helios Gene Gun (Bio-Rad Laboratories) 36–48 
hours after dissociation in 2:1:1 ratio respectively. As a negative control, pmTurquoise 2 (tag 
only) was co-transfected instead of the auxiliary subunits. For peptide studies, only Nav1.6r 
and Nav1.8 shRNA-IRES-dsRED were co-transfected. Expression of the Nav1.6r construct 
with Nav1.8 shRNA allowed us to study the modulation of Nav1.6r by auxiliary subunits in 
isolation from endogenous channels as previously described (3, 28). Although endogenous 
TTXR Nav1.8 channels run down in culture (17, 28), by using the Nav1.8 shRNA-IRES-
dsRED plasmid we further decreased Nav1.8 to minimize contamination. TTXR Nav1.9 
currents are not observed under our recoding parameters as previously reported (7, 11). 
Endogenous TTXS channels were blocked with 500nM.
Electrophysiology and Data Analysis
General Setup—Whole-cell patch-clamp recordings obtained with a HEKA EPC-10USB 
amplifier. Data were acquired on a Windows-based Intel 2 Core computer using the 
Patchmaster program (version 2X65; HEKA Elektronik). Fire polished glass electrodes 
(0.7–1.1 MΩ) were fabricated using a P-97 puller (Sutter), and tips were coated with dental 
wax to minimize capacitive artifacts and enhance series resistance compensation. The offset 
potential was zeroed prior to seal formation. Capacitive transients were canceled using 
computer-controlled circuitry; C-fast for pipette-capacitance correction and C-slow for cell-
capacitance compensation. Voltage errors were minimized by series resistance compensation 
>75%. Membrane currents were sampled at 20 KHz and filtered online at 10 KHz. Leak 
currents were linearly cancelled by P/-5 subtraction (pulse/number). Whole-cell patch-clamp 
recordings in voltage clamp mode were obtained 2–3.5 days after transfection at room 
temperature (~22 °C). Cells examined were selected based on fluorescence of Turquoise 
(corresponding to auxiliary subunit) and dsRed (corresponding to Nav1.8 shRNA) signal. 
For peptide studies, the dsRed signal only was used as selection criteria since no auxiliary 
subunits were co-transfected. Cells with residual Nav1.8 current greater than 3% of the peak 
current of Nav1.6r were excluded. Nav1.8 contamination was determined by examining the 
voltage-dependence of steady-state fast inactivation as described previously (3). Whole-cell 
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voltage clamp recordings were started five minutes after the whole-cell configuration was 
obtained.
For current-clamp recordings, DRG neurons were allowed to settle at their resting potential. 
Spontaneous activity was defined as firing observed during 2 minutes with zero current 
injection. DRG neurons were examined for evoked activity with a series of 2 s current 
injection from 100 pA to 500 pA in 100 pA increments. For evoked activity, the maximum 
number of action potentials elicited from each cell was determined as the maximum action 
potentials elicited from current injections from 0 to 500 pA. Electrophysiology data were 
analyzed using the software programs Origin (version 8, OriginLab), Fitmaster (v2X65, 
HEKA Electronik), Excel (Microsoft) and final graphs were made in Prism (version 6, 
GraphPad).
Recording solutions—The electrode solution consisted of 140 mM CsF, 10 mM NaCl, 
1.1 mM EGTA, and 10 mM HEPES (adjusted to pH 7.3 with CsOH). The extracellular 
bathing solution contained 130 mM NaCl, 30 mM TEA chloride, 1mM MgCl2, 3 mM KCl, 
1mM CaCl2, 0.05 mM CdCl2, 10 mM HEPES and 10 mM D-glucose (adjusted pH 7.3 with 
NaOH). For current-clamp recordings, the pipette solution contained 140 mM KCl, 0.5 mM 
EGTA, 5mM HEPES and 3 mM Mg-ATP (adjusted pH 7.3 with KOH). The extracellular 
solution contained 140 mM NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM CaCl2 and 10 mM 
HEPES (adjusted pH 7.3 with NaOH). Recording solutions were adjusted using D-glucose 
to maintain physiological osmolarity values.
Peptide Experiments—To study the effects of FHF2A`s long-term inactivation particle, 
we used a peptide corresponding to amino acids residues 2–21 as reported in (16). The 
peptide, FHFA, was modified with an N-terminal acetyl group and C-terminal hydroxyl 
group yielding the following sequence: Ac-AAAIASSLIRQKRQAREREK-OH (purchased 
from Biopeptides Co). The FHFA peptide was added to the electrode solution at a 1mM 
concentration. Control groups included either having no peptide added to the intracellular 
solution or adding an inactive mutant FHFA-5Q peptide (Ac-
AAAIASSLIRQQQQAQEQEQ-OH from Biopeptides Co) to the electrode solution at a 
1mM concentration.
Steady-State Activation—Current-voltage (I/V) relationships were determined by steps 
of 50 ms, from −100 to + 80mV, in 5 mV increments. The voltage-dependence of activation 
(m∞) was determined from sodium currents elicited with I/V protocol from voltages of −100 
mV to 0 mV. Conductance (G) values were calculated at each test potential (Vm) using the 
reversal potential (Vr) with following equation, . Data was then normalized to 
the peak conductance, plotted as a function of voltage and fitted using single-phase 
Boltzmann distribution equation, . The midpoint points (V1/2) 
and slope factor (k) were obtained for each cell.
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Steady-State Inactivation—Steady-state fast inactivation (h∞) was assayed with 500 ms 
pre-pulses from −130 to 5 mV (in 5 mV increments) followed by a 20 ms test pulse to −20 
mV to assess channel availability. Current Peak currents at each pre-pulse were normalized 
to the overall peak current. Data of normalized currents as a function of voltage was fitted 
with the single phase Boltzmann distribution, , from which the 
midpoint points (V1/2) of steady-state fast inactivation and slope factor (k) were obtained for 
each cell. Additionally, current densities were estimated for each individual recording by 
dividing the peak transient currents obtained from h∞ by the membrane capacitance.
Recovery from Inactivation—Recovery from Inactivation was assayed with a two-pulse 
protocol that depolarized the membrane to −20 mV for 20 ms from holding potential 
(−100mV). The time between the pulses was increased by an additive 2n factor, where 
n=sweep number. At each time point the peak current measured in the second pulse (I2) was 
normalized to the peak current measured in the first pulse (I1), yielding fraction available. 
Fraction available  was plotted as a function of time (t) and fitted to a double 
exponential equation, , from which we obtained 
the recovery time constants for the fast (τfast) and slow component (τslow) and compared 
between groups.
Accumulation of long-term inactivation—Cells were assayed with a four-pulse 
protocol, as previously described (16), to measure long-term inactivation. Each pulse 
depolarized the membrane to −20 mV for 16ms from a holding potential of −90mV with 
−90mV 40 ms interpulse recovery phases between each depolarization pulse. Peak current 
measured at each pulse was normalized to overall peak current to yield percentage of sodium 
channels available. The % of channels available was plotted as a function of depolarization 
cycle (i.e. pulse number).
Resurgent Current—Cells were assayed with a two-pulse protocol that initially 
depolarized the membrane to +30 mV for 20 ms from the holding potential (−100mV), 
followed by repolarizing voltage steps from +15 mV to −80 for 100 ms in −5 mV increments 
to test for resurgent currents; cells were then returned to their holding potential (−100mV). 
Resurgent currents display unique characteristics of slow onset and slow decay along with a 
non-monotonic I/V relationship. Currents that did not meet these criteria were classified as 
negative for resurgent currents. Based on these criteria, the percentage of DRG that were 
positive/negative for detectable resurgent current was quantified for each condition. 
Resurgent current amplitudes were measured after 3.0 ms into the repolarizing pulse to 
avoid contamination from tail currents. Peak resurgent current amplitude at each test 
potential was normalized to peak transient current (obtained from the h∞ protocol) and 
expressed as a percentage of peak transient current. Normalized resurgent current amplitude 
was plotted as a function of voltage.
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Statistics
Data are presented as mean ± standard error of the mean (SEM). The data were tested for 
Gaussian distribution fit with D’Agostino & Pearson omnibus normality test. Data that fit 
Gaussian distribution were compared with parametric test, Student’s t-test at a 95% level of 
confidence (α=0.05). Data that did not fit Gaussian distribution were compared with a non-
parametric Mann-Whitney Test with 95% level of confidence (α=0.05). The Chi-square test 
(X2 test) was used to compare the frequency distribution of resurgent current positive/
negative neurons and repetitive action potential firing between groups at a 95% level of 
confidence (α=0.05).
RESULTS
Biophysical Properties of Nav1.6r with FHF2A and FHF2B
We first examined if in DRG neurons FHF2A could mediate the characteristic long-term 
inactivation that has been reported in other cells with FHFAs variants (16, 48). Primary 
cultured DRG neurons were biolistically co-transfected with Nav1.6r and tagged-FHF2A or 
tagged-FHF2B. As a negative control, tag only (pmTurquoise2; fluorescent protein) was 
transfected instead of a FHF subunit. Whole-cell voltage-clamp recordings of isolated 
Nav1.6r were obtained by pharmacological (addition of 500 nM TTX) and genetic 
(Nav1.8shRNA; see Methods) inhibition of endogenous DRG sodium currents. Long-term 
inactivation was measured using a four-pulse protocol consisting of depolarizations to 
−20mV for 16ms with 40ms interpulses at −90 mV as described by Dover et al, 2010 (16). 
Representative traces obtained with this long-term inactivation assay are shown in Fig. 1a 
for each group. Overexpression of FHF2A increased accumulation of Nav1.6r in long-term 
inactivated states, consistent with previous reports (16, 48). FHF2A progressively decreased 
Nav1.6r availability with each depolarization cycle relative to control (Fig. 1b, minimum 
sodium channel availability p p<0.0001: FHF2A 72 ± 3%, n=18; Control 90 ± 2%, n=28), 
whereas, FHF2B did not (p=0.62, FHF2B 91 ± 2%, n=13).
We also examined how FHF2A and FHF2B alter other biophysical properties of Nav1.6r in 
DRG neurons since in different cell backgrounds FHFs’ interaction with VGSCs have been 
reported to alter current density, inactivation, activation and recovery as previously discussed 
(43). Current-voltage (I/V) relationship was determined with a single pulse protocol that 
ranged from −100 to 80mV for 50ms. Using the I/V protocol we quantified peak current 
density and activation. Overexpression of FHF2A or FHF2B did not alter peak current 
density of Nav1.6r relative to control (Table 1, p=0.32 and p=0.37 respectively). FHF2A did 
shift the voltage dependence of activation to more positive potentials (Fig. 1c, p=0.0063), 
whereas FHF2B did not, relative to control (Table 1, p=0.50). Steady-state inactivation was 
assayed by conditioning the cells with a pre-pulse that ranged from −130 to 5mV for 500ms 
followed by a test pulse to −20mV for 20ms. Consistent with previous reports (48, 59, 60, 
63), FHF2A and FHF2B shifted the voltage dependence of inactivation to more depolarized 
potentials (Fig. 1d, p=0.0013 and p=0.026 respectively). Recovery from inactivation was 
assayed with a two-pulse step protocol that depolarized the membrane to −20mV for 20ms 
with increasing time between pulses (recovery phases). Fig. 1e shows that FHF2A slowed 
recovery from inactivation (Table 1; τfast, p=0.16 and τslow, p=0.012), whereas, FHF2B 
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enhanced recovery from inactivation relative to control (Table 1; τfast, p<0.0001 τslow, 
p=0.03). Table 1 shows a summary of recovery, inactivation, activation and current density 
data.
Differential modulation of fast resurgent currents by FHF2A and FHF2B
We next investigated resurgent current modulation by these FHF2 isoforms. To do so we 
used a two-pulse protocol that initially depolarized the cell membrane to 30mV for 20ms 
followed with a series of repolarization pulses from +15 to −80 mV for 100ms. Resurgent 
current amplitudes were normalized to classic sodium peak current (maximum current 
obtained from the steady-state inactivation protocol) and expressed as percentage of peak 
current. Representative traces of resurgent currents are shown in Fig. 2a for each group. 
Overall FHF2A reduced the fraction of resurgent current positive neurons (X2 test, p=0.039), 
whereas FHF2B did not, relative to control (Fig. 2b, p=0.60). FHF2A also reduced resurgent 
current amplitude relative to control (Fig. 2c Peak Resurgent Current Amplitude p=0.0021: 
FHF2A 0.371 ± 0.21%, n=18; Control 1.14 ± 0.27%, n=29). FHF2B exhibited the opposite 
effect, doubling peak resurgent current amplitude relative to control (p=0.0034: FHF2B 2.41 
± 0.22%, n=13).
FHFA peptide replicates long-term inactivation effects and reduced Nav1.6r mediated 
resurgent currents
FHF2A has two known potential interactions that might contribute to Nav1.6r modulation: 
1) binding to the C-terminal of sodium channels and 2) long-term inactivation particle 
binding (presumably to the inner pore region). We hypothesized that FHF2A’s long-term 
inactivation particle is the main contributor for the observed negative regulation of fast 
resurgent currents. To explore this possibility, we used a peptide (FHFA peptide) 
corresponding to amino acid residues 2–21 in FHF2A protein, previously identified as the 
long-term inactivation particle (16). FHFA peptide (1mM) was added to the internal 
recording solution as described by Dover et al, 2010. DRG neurons were transfected with 
Nav1.6r and recombinant currents were isolated as described in the methods section. Voltage 
clamp recordings were obtained five minutes after dialysis of the internal solution in the 
presence or absence of the peptide. Using the protocols previously described we examined 
current density, activation, inactivation, recovery, long-term inactivation and resurgent 
currents. Representative traces of long-term inactivation test are shown in Fig. 3a–b. Dialysis 
of the FHFA peptide greatly increased accumulation of Nav1.6r in long-term inactivated 
states (Fig. 3c, minimum sodium channel availability p<0.0001: +FHFA 29 ± 3%, n=15; 
−FHFA 84 ± 2%, n=16). Recovery from inactivation was significantly slowed in the +FHFA 
peptide group relative to the −FHFA peptide group (Fig. 3d and Table 2; τfast, p=0.034 and 
τslow, p=0.012). Addition of the FHFA peptide did not alter Nav1.6r current density 
(p=0.054), voltage dependence of activation (p=0.21) or inactivation relative to control 
(p=0.95). Table 2 shows a summary of current density, activation and inactivation data. We 
next examined resurgent currents with a two-step protocol as previously described. 
Representative traces of peak Nav1.6r resurgent currents are shown in Fig. 3e. The +FHFA 
peptide group exhibited reduced resurgent current amplitudes relative to −FHFA peptide 
group (Fig. 3f, peak resurgent current p<0.0001: +FHFA Peptide 0.3 ± 0.2, n=15; −FHFA 
Peptide 1.5 ± 0.4%, n=16). The fraction of resurgent current positive neurons was also 
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greatly reduced in the +FHFA peptide group (Chi-square test p=0.0032: 20%, n=15) relative 
to control −FHFA peptide (69%, n= 16). An additional set of experiments was performed to 
determine if these effects were specific to the FHFA peptide or could be induced by any 
peptide. Dover et al. showed that substitution of five charged residues in the N-terminus of 
FHF2A with glutamines eliminates the ability of FHF2A to induce long-term inactivation 
(16). We synthesized the corresponding FHFA-5Q peptide and added it at 1 mM to the 
internal recording solution. When neurons recorded with FHFA-5Q peptide (n=14) were 
compared to neurons recorded with no added peptide (n=7) there was no difference in terms 
of accumulation in long-term inactivated states (p=0.66), kinetics of recovery from 
inactivation (p=0.90) and resurgent current amplitude (p=0.74), indicating that FHFA 
peptide effect is dependent on the specific amino acid sequence.
Modulation of Nav1.6r by chimeric constructs of Navβ4 and FHF2A
The FHF2A long-term inactivation particle is potentially inhibiting fast resurgent currents by 
out-competing the open-channel blocker Navβ4 (3). Therefore, we investigated if replacing 
the proposed open-channel blocker sequence in Navβ4 with FHF2A’s long-term inactivation 
sequence would transfer the long-term inactivation activity and reduce resurgent currents in 
DRG neurons. Conversely, we replaced the long-term inactivation sequence in FHF2A with 
the open channel blocker in the Navβ4 protein and hypothesized that this construct would 
increase resurgent current. The sequences were codon optimized and synthetically made (see 
Methods section). The resulting chimeric constructs were named F2A(β4) for the FHF2A 
protein containing the Navβ4 open channel sequence and β4(F2A) for the Navβ4 protein 
containing the FHF2A long-term inactivation sequence (Fig. 4). Both constructs were tagged 
at the C-terminus with a fluorescent protein, pmTurquoise2, to verify expression. DRG 
neurons were biolistically transfected with Nav1.6r and a chimeric construct. As a control, 
tag only was expressed instead of a chimeric subunit. Nav1.6r currents were isolated 
following inhibition of endogenous sodium currents as previously described. Using the 
recording protocols previously described we examined the biophysical properties of Nav1.6r 
with co-expression of β4(F2A) or F2A(β4) and investigated if the chimeric constructs 
modulated resurgent currents. Representative traces from a long-term inactivation protocol 
test for each group are shown in Fig. 5a. β4(F2A) slightly increased accumulation of long-
term inactivation relative to control (Fig. 5b: minimum sodium channel availability p=0.034: 
β4(F2A) 84 ± 2%, n=12; Control 89 ± 2%, n=14), whereas, F2A(β4) did not alter 
accumulation of long-term inactivation (88 ± 2%, n=9). Expression of either chimera, 
β4(F2A) or F2A(β4) did not alter current density relative to control (Table 3, p=0.82 and 
p=0.35 respectively). In a similar pattern as seen with FHF2A, F2A(β4) expression shifted 
the voltage dependence of activation (Fig. 5c, p=0.047) and inactivation (Fig. 5d, p=0.0089) 
of Nav1.6r to positive potentials relative to control, whereas β4(F2A) did not alter either 
(Table 3, p=0.36 and p=0.29, respectively). Expression of F2A(β4) enhanced Nav1.6r 
recovery from steady-state inactivation relative to control (Fig. 5e Inset; τfast, p=0.0010 and 
τslow, p=0.36). β4(F2A) did not slow or enhance Nav1.6r recovery from inactivation 
relative to control (Fig. 5e and Table 3; τfast, p=0.50 and τslow, p=0.36).
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Differential modulation of fast resurgent currents by F2A(β4) and β4(F2A) chimeras
We next examined Nav1.6r mediated resurgent currents with a two-step protocol (Methods 
section). Resurgent current amplitude was expressed as percentage of peak current. 
Representative traces of resurgent currents for each condition are shown in Fig.6a. Fig. 6b 
shows the distribution of resurgent current positive and resurgent current negative neurons 
for each condition. Overall the percentage of resurgent current positive neurons was not 
significantly different with expression of β4(F2A) or F2A(β4) relative to control (p=0.30 
and p=0.52, respectively). The percentage of resurgent current positive neurons was 33% for 
β4(F2A), 67% for F2A(β4) and 53% for control. However, F2A(β4) expression increased 
resurgent current amplitude by three-fold factor relative to control (Fig. 6c peak resurgent 
current p=0.0023: F2A(β4) 3.1 ± 0.8%, n=9; Control 1.2 ± 0.4%, n=15). In contrast, 
β4(F2A) exhibited the opposite effect reducing resurgent current amplitude by two-fold 
factor (β4(F2A) p=0.0076: 0.4 ± 0.2%, n=12).
FHFa in a radicular inflammatory pain model
The results of overexpression of FHF2A and FHF2B, FHFA peptide and chimeric constructs 
suggest that FHF2A and FHF2B isoforms regulate resurgent currents and may contribute to 
pain pathologies. We previously reported that resurgent currents are increase in a rat model 
of radicular pain (71). In this model, localized inflammation of the DRG (LID) causes 
persistent mechanical hyperalgesia and allodynia that starts as soon as post-operative day 1 
(67–69, 71). Therefore, we chose to examine FHF2A and FHF2B expression and the effect 
of FHFA peptide on neuronal excitability using acutely cultured neurons harvested from rats 
on day 5 following LID. To examine FHF2A and FHF2B expression, Sprague Dawley Rats 
were injected with zymosan at a 2mg/mL concentration above the L4 and L5 DRG on one 
side (see Methods). Sham operated rats that underwent the same procedure with the 
exception of the injections were used as a control. In order to confirm that the LID but not 
the sham procedure used evoked pain behaviors on the day the animals were sacrificed for 
obtaining cultured DRG neurons, behavioral measures of mechanical and cold 
hypersensitivity were measured at baseline and for 5 days after DRG inflammation or sham 
surgery. As shown in Supplementary Fig. S1, static and dynamic mechanical allodynia and 
cold allodynia were significantly elevated in LID animals compared to sham animals, 
starting as early as POD1 and continuing through POD5. At post-operative day 5, L4/L5 
ipsilateral DRG were harvested from LID and Sham operated animals. FHFA and FHF2B 
levels were examined in primary DRG cultures with immunocytochemistry. One caveat with 
the FHFA antibody used is that it is not selective to the FHF2A isoform, but rather the 
antibody used targets the long-term inactivation particle which is highly conserved between 
all FHFAs. However, in adult DRG neurons, FHF4A is not expressed and FHF1A is 
downregulated in adulthood (27). FHF1A contains a nuclear localization signal that is 
functional in DRG neurons and targets the protein to the nucleus (27). In contrast, FHF2A 
nuclear localization signal is predicted to be inactive since staining is limited to the cell 
periphery and not detected in the nucleus in adult DRG neurons (48). Therefore, given that 
our model is an adult DRG neuron we expect that cross-reaction is minimal and likely most 
of the antibody signal is reflecting FHF2A expression. Representative images of FHFA 
staining in acutely cultured neurons are shown in Fig. 7a–b. Inflammation of the DRG 
reduced FHFAs levels relative to Sham control (Fig. 7c, FHF2A Mean Intensity p<0.0001; 
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LID 13.0 ± 0.3 AU., n=1989, Sham 24.8 ± 0.8 AU, n=1116). In contrast, FHF2B expression 
was modulated in the opposite direction as FHFAs. Representative images of FHF2B 
staining are show in Fig.7d–e. FHF2B was upregulated in the LID group relative to Sham 
control (Fig.7f, FHF2B Mean Intensity p<0.0001; LID 29.5 ± 1.6 AU, n=1121, Sham 21.04 
± 0.4 AU, n=1164).
Previously we have shown that local inflammation of the L4/L5 DRG increases spontaneous 
activity of Aβ neurons and resurgent currents in cultured medium diameter neurons (71). 
These effects are attenuated by Navβ4 knockdown. Here we asked if LID induced neuronal 
hyperexcitability could be affected by the FHFA peptide. For this set of experiments we 
recorded action potential activity from medium diameter neurons harvested from sham and 
LID treated rats with either 1 mM FHFA peptide or 1 mM FHFA-5Q peptide in the 
intracellular pipette solution. Neurons from sham animals did not exhibit any spontaneous 
activity (Fig. 8a–b) with either FHFA-5Q peptide (n=12) or FHFA peptide (n-10) in the 
pipette solution. By contrast, 3 of 10 neurons from LID treated animals exhibited 
spontaneous activity with FHFA-5Q peptide in the recording solution (Fig. 8c–d). This is 
similar to what was observed previously with microelectrode recordings from Aβ fibers in 
an acutely isolated whole DRG preparation (68, 71). By contrast, no spontaneous activity 
was observed in neurons when wildtype FHFA peptide was included in the internal 
recording solution (n=14) and this difference was significant (p=0.02846; Chi-square test). 
Evoked action potential firing was also examined with current injections in the four groups. 
In both sham and LID treated neurons the wildtype FHFA peptide substantially reduced the 
number of action potentials compared to the FHFA-5Q peptide (Fig. 8e–h). Significantly 
more neurons generated multiple action potentials in response to current injections with 
FHFA-5Q in the pipette than with wildtype FHFA peptide in the pipette (p=0.00104; Chi-
square test).
DISCUSSION
In this study we show that FHF2A and FHF2B differentially regulate resurgent sodium 
currents in DRG sensory neurons. The first component of our hypothesis was FHF2A limits 
the capacity of sensory neurons to generate fast resurgent currents by mediating long-term 
inactivation. Three main findings support this hypothesis. First, overexpression of FHF2A 
reduced resurgent current and increased accumulation of channels in inactivated states 
resulting in delayed channel recovery. Secondly, a peptide derived from FHF2A`s long-term 
inactivation particle recapitulated the reduction in resurgent current generation and the 
enhancement of long-term inactivation. The peptide did not modulate the voltage 
dependence of inactivation and activation as seen with full length FHF2A, suggesting these 
changes do not account for negative regulation of resurgent current. A mutant peptide 
(FHFA-5Q) was inactive. Thirdly, the F2A(β4) chimera (in which the long-term inactivation 
particle was replaced with Navβ4’s open channel blocker sequence) did not negatively 
regulate resurgent currents nor induced long-term inactivation. The chimera produced the 
opposite effect, an enhancement in resurgent current modulation, suggesting the long-term 
inactivation particle region is key for FHF2A`s resurgent current modulation.
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The second component of our hypothesis was FHF2B increases resurgent currents by 
delaying inactivation. Our results support this hypothesis. FHF2B increased resurgent 
current, shifted the voltage dependence of inactivation to positive potentials and enhanced 
channel recovery. FHF2B’s inability to mediate long-term inactivation while shifting 
inactivation to positive potentials likely increased the accessibility of the putative open 
channel blocker. The faster recovery observed with overexpression of FHF2B supports this 
possibility, since recovery when the channel undergoes open-channel block is reported to 
occur in a shorter time scale than channel recovery from fast inactivation (46). An alternative 
explanation is that FHF2B displaces the endogenous negative regulation exerted by FHF2A 
because all FHFs are predicted to bind to a conserved region in C-terminus of VGSCs (18). 
FHF2A is expressed in neurons of all size classes and is particularly predominant in small 
diameter neurons (48). The transfected neurons examined in these studies were mostly in the 
small diameter range. Therefore, it is plausible that displacement of endogenous FHF2A by 
exogenous FHF2B contributes to some extent to FHF2B’s positive regulation of fast 
resurgent currents.
Based on previous reports, the potential mechanism for FHF2A negative regulation is 
competition of the long-term inactivation particle with the Navβ4 open-channel blocker (3, 
57). The results from FHF2A and Navβ4 chimeras partially support this hypothesis, however 
the implications of the results obtained with these chimeric proteins is limited by a few 
caveats. Our assumption was that by replacing the peptide sequence of long-term 
inactivation with the open-channel blocker and vice-versa the activity would be retained in 
the resulting chimera. However, the β4(F2A) chimera failed to delay channel recovery and 
produced a very mild enhancement in accumulation of inactivated states; suggesting that the 
long-term inactivation particle is not fully functional in the β4(F2A) chimeric construct. 
Therefore, the reduction in resurgent current observed with the expression of the β4(F2A) 
chimera is likely due to a dominant negative effect of an inactive Navβ4. In a similar 
manner, there are two possible contributions to F2A(β4)’s resurgent current enhancement: 1) 
the Navβ4 open channel blocker sequence is active in the chimera and 2) loss of the long-
term inactivation particle allowed other changes in the voltage dependence to favor the 
endogenous open channel blocker interaction as seen with FHF2B. To further explore the 
first possibility, we tested the F2A(β4) chimera in a Nav1.5 HEK cell line that does not 
generate resurgent current unless the β4-peptide is introduced. We found that indeed the 
F2A(β4) chimera mediated resurgent currents (Supplementary Fig. S2) in the Nav1.5 cell-
line. This result favors the possibility that F2A(β4) chimera retains open-channel blocker 
activity. However, it would be simplistic to assume that the resurgent current enhancement is 
only due to this activity. It is likely a combined effect of removing a limiting determinant 
(i.e. long-term inactivation particle), adding an active open channel blocker sequence and the 
shift in voltage dependence of inactivation contributing to the overall enhancement of 
resurgent current. Overall, results from β4(F2A) and F2A(β4) chimeras confirmed that 
regions of the N-terminus of FHF2A and the C-terminus of Navβ4 are important modulators 
of fast resurgent currents.
FHFs binding to C-terminus of VGSC can cause changes in the biophysical properties of the 
VGSC (77). Expression of FHF2A, FHF2B or F2A(β4) shifted the voltage dependent 
inactivation to positive potentials. Since the F2A(β4) chimera lacks the long-term 
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inactivation particle sequence yet retained the ability to cause shifts in voltage dependence 
of activation and inactivation, the results suggest that these modulations are mainly an effect 
of the FHF2 core region binding to the C-terminus of Nav1.6. The shift of inactivation to 
positive potentials is consistent with previous reports of FHF2 binding to the C-terminus of 
different sodium channels including Nav1.6 (18, 48, 60, 63). FHF2A and F2A(β4) also 
shifted activation to positive potentials. Since both F2A(β4) and FHF2A but not FHF2B 
exerted this effect, it most likely that the N-terminus region that is conserved between 
F2A(β4) and FHF2A is responsible for this effect.
Interestingly, the chimeras generated for this study might serve as valuable tools for the 
study of resurgent currents in the future. The (β4)F2A chimera did not significantly alter the 
voltage dependence of activation or inactivation, recovery from inactivation, or current 
density. The main effect we detected was a significant reduction in resurgent current. As 
such, overexpression of this protein in animal models or in-vitro studies might serve as a 
tool to selectively target attenuation of resurgent currents. On the other hand, the F2A(β4) 
chimera might serve as a tool to artificially induce fast resurgent currents. The applications 
for the F2A(β4) might be limited since it alters other channel properties. However, we 
envisioned that the F2A(β4) chimera might be useful in high-throughput assays to identify 
compounds that might inhibit resurgent currents.
Overall our data suggest that FHF2A and FHF2B modulate resurgent currents in DRG 
neurons. The importance of this finding is more evident when we examine how these 
proteins are regulated in a radicular pain model induced by localized inflammation of the 
DRG. Our results show that after inflammation FHFAs isoforms are downregulated in 
acutely isolated neurons, whereas FHF2B was upregulated. We speculate that changes in 
expression of these isoforms likely contribute to the increased resurgent current generation 
and hyperexcitability reported in this model (69, 71, 73). The limitation of the antibody 
specificity precludes us from definitively contributing the effect solely to changes in the 
FHF2A isoform. However, the high conservation of the long-term inactivation particle 
between all FHFAs suggest that if other FHFAs were to interact with Nav1.6 they will likely 
have a similar negative regulation on resurgent currents. Indeed, we find that the FHFA 
peptide is able to reduce sensory neuron action potential firing and the enhanced 
spontaneous activity that is observed in acutely isolated neurons following localized 
inflammation of the DRG. FHFs modulation might also contribute to other pain pathologies. 
For example, two studies using cDNA arrays reported FHF2 cDNA levels downregulated 
with no change in FHF1 and FHF4 after peripheral nerve injury (35, 65). Using Expression 
Atlas (45) from European Bioinformatics Institute and European Molecular Biology 
Laboratory we found that FHF1 and FHF2 levels are downregulated in DRG neurons after 
spinal nerve ligation, a chronic pain model. Data corresponded to a RNAseq study by 
Hammer et al, 2010 (23). Which of the FHF1 and FHF2 isoforms contribute most to these 
changes is unknown. Our study suggests that FHFs might prove to be novel targets for 
regulating fast resurgent current in DRG neurons and further study might provide new 
insight into possible therapeutic strategies for pain.
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Abbreviations
DRG Dorsal root ganglia
INaR Resurgent sodium current
FHF Fibroblast growth factor Homologous Factor
CNS Central Nervous System
PNS Peripheral Nervous System
shRNA small hairpin Ribonucleic Acid
cDNA complementary deoxyribonucleic acid
LTI long-term inactivation
HEK Human Embryonic Kidney
VGSC Voltage Gated Sodium Channel
TTX Tetrodotoxin
TTXS Tetrodotoxin-Sensitive
TTXR Tetrodotoxin-Resistant
LID Localized Inflammation of the DRG
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Fig. 1. Biophysical properties of Nav1.6r modulated by FHF2A and FHF2B
DRG neurons were transfected with Nav1.6r and FHF2A, FHF2B or fluorescent protein tag 
(control). a, Representative traces of cycle-dependent reduction as a measure of 
accumulation of long-term inactivation (LTI) for control (black), FHF2A (blue) and FHF2B 
(purple) groups. b, The percentage of channels available as a function of depolarization 
cycle shows overexpression of FHF2A (n=19) increased accumulation of long-term relative 
to control (n=28), whereas, FHF2B (n=13) did not. Activation, inactivation and recovery 
from inactivation were assayed with a series of standard protocols (see Methods sections). c, 
Normalized conductance (G/Gmax) as a function of voltage shows that FHF2A (blue 
squares, n=16) overexpression shifted the voltage dependence of activation relative to 
control (black circles, n=25). No change is observed for FHF2B overexpression (purple 
diamonds, n=11) relative to control. d, Normalized current (I/Imax) as a function of voltage 
shows that voltage dependence of inactivation was shifted to positive potentials in FHF2A 
(n=19) and FHF2B (n=13) groups relative to control (n=27). e, Fraction of channels 
available as a function of time shows FHF2A (n=19) overexpression greatly slowed recovery 
from inactivation relative to control (n=15), whereas, FHF2B (Inset, n=12) enhanced 
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channel recovery. Abbreviations: LTI-Long-term Inactivation; Asterisks (*) represent p 
<0.0001 obtained from Student’s t-test. Data are mean ± SEM.
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Fig. 2. FHF2A and FHF2B differentially regulate fast resurgent currents
a, Representative traces of Nav1.6r mediated resurgent currents obtained from cultured DRG 
neurons with corresponding peak resurgent currents highlighted for control (black), FHF2A 
overexpression (blue) and FHF2B overexpression (purple) conditions. b, The distribution of 
resurgent current positive (+INaR)/resurgent current negative (−INaR) DRG neurons was not 
different with FHF2B (n=13) overexpression relative to control (n=29). FHF2A (n=18) 
overexpression significantly decreased the percentage of DRG neurons that generated 
resurgent currents relative to control (p<0.0005, X2 test). c, Normalized resurgent current 
amplitude as a function of voltage shows FHF2A overexpression (blue squares) decreased 
resurgent current amplitude in a range of voltages relative to control (black circles). In 
contrast, FHF2B overexpression (purple triangles) increased resurgent current amplitude in a 
range of voltages. Asterisks (*) represent p <0.05 obtained from Student’s t-test. Data are 
mean ± SEM.
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Fig. 3. FHFA peptide exhibits long-term inactivation activity and recapitulates resurgent current 
reduction effects
Nav1.6r currents were isolated in DRG neurons and recordings were obtained in the 
presence (+) or absence (−) of FHFA peptide in the recording pipette. Representative traces 
of cycle-dependent reduction as a measure of accumulation of long-term inactivation (LTI) 
are shown for −FHFA peptide group (a, black) and +FHFA peptide group (b, pink). c, The 
percentage of channels available as a function of depolarization cycles shows that addition 
of the FHFA peptide (black circles, n=15) significantly increased accumulation of channels 
in long-term inactivated states relative to −FHFA peptide group (pink squares, n=14). d, 
Recovery from inactivation was greatly slowed in +FHFA peptide group (n=15) relative to 
−FHFA peptide group (n=14). e, Representative traces of Nav1.6r mediated resurgent 
currents with peak currents highlighted for −FHFA peptide (black) and +FHFA peptide 
(pink) groups. f, Compared to −FHFA peptide (black circles, n=15), addition of the FHFA 
peptide (pink squares, n=16) reduced resurgent current amplitude. Note resurgent currents 
were normalized to peak transient currents and plotted as a function of voltage. 
Abbreviations: LTI-Long-term Inactivation. Asterisks (*) represent p<0.05 obtained from 
Student’s t-test. Data are mean ± SEM.
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Fig. 4. Chimeric constructs of FHF2A and Navβ4
a, Illustration of FHF2A and Navβ4 subunits. The Navβ4 subunit consists of an extracellular 
N-terminal domain, a single transmembrane domain and a cytosolic C-terminal domain. The 
cytosolic domain contains a sequence of amino acids proposed to mediate open channel 
block that generate resurgent currents (red sphere represents β4 peptide sequence, amino 
acids 183–203(2, 33)). The FHF2A subunit is a cytosolic protein, which contains a core 
region homologous to all FHF with a C-terminal epitope that enables interaction with the 
cytoplasmic C-terminal region of sodium channels (18). Distinct from its FHF2B 
counterpart, the FHF2A N-terminus sequence is much longer and contains a sequence 
identified as the long-term inactivation particle (blue sphere, amino acids 1–20 (16)). Arrow 
between the subunit highlights the region that was exchanged between these subunits to 
generate the chimeric constructs. b, Illustration of the resulting chimeric constructs. The 
(β4)F2A contains all components of the Navβ4 subunit with the exception of β4-peptide 
sequence, which was replaced with long-term inactivation particle sequence. The F2A(β4) 
contains all domains of the FHF2A protein except the long-term inactivation particle, which 
was replaced with the β4 peptide sequence. Inset, depicts the figure legend for the β4-
peptide and long-term inactivation particle with the corresponding amino acid sequence.
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Fig. 5. Biophysical properties of Nav1.6r modulated by β4(F2A) and F2A(β4) chimeras
Activation, inactivation and recovery from inactivation were assayed with a series of 
standard protocols (see Methods sections). a, Representative traces of cycle-dependent 
reduction as a measure of long-term inactivation (LTI) for Nav1.6r isolated currents in DRG 
neurons with co-expression of fluorescent tag (control, black), F2A(β4) (green) and β4-F2A 
(orange). b, The percentage of channels available as a function of depolarization cycle shows 
increased accumulation of long-term inactivation for β4(F2A) group (orange squares, n=12) 
relative to control (black circles, n=16), whereas no difference is observed for F2A(β4) 
group (green triangles, n=8) relative to control. c, Normalized conductance as a function of 
voltage shows that co-expression of F2A(β4) (n=8) shifted the voltage dependence of 
activation to positive potentials relative to control (n=14), whereas, no change is observed 
for the β4(F2A) group (n=12). d, Normalized current as a function of voltage shows that co-
expression of F2A(β4) (n=9) shifted the voltage dependence of steady-state inactivation to 
positive potentials relative to control (n=14), whereas, no change is observed for the 
β4(F2A) group (n=12). e, Fraction of current available as a function of time shows that 
recovery is not significantly altered with co-expression of either chimera β4(F2A) (n=12) or 
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F2A(β4) (n=9) relative to control (n=14). Asterisks (*) represent p<0.05 obtained from 
Student’s t-test. Data are mean ± SEM.
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Fig. 6. β4(F2A) and F2A(β4) differentially modulate fast resurgent currents
a, Representative traces of Nav1.6r mediated resurgent currents obtained from cultured DRG 
neurons with corresponding peak resurgent currents highlighted for control (black), β4(F2A) 
(orange) and F2A(β4) (green) groups. b, Neither co-expression of (β4)F2A (n=12) nor co-
expression of F2A(β4) (n=9) altered the distribution of resurgent current positive (+INaR)/
resurgent current negative (−INaR) DRG neurons relative to control (n=16). c, Resurgent 
current amplitude was decreased with co-expression of β4(F2A) (orange squares, n=12) in a 
range of voltages relative to control (black circles, n=15). In contrast, co-expression of 
F2A(β4) (green triangles, n=9) chimera increased resurgent current amplitude in a range of 
voltages relative to control. Note that resurgent currents were normalized to peak transient 
currents and plotted as a function of voltage. Asterisks (*) represent p <0.05 obtained from 
Student’s t-test. Summary data are mean ± SEM.
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Fig. 7. FHFA and FHF2B levels are differentially altered after local inflammation of the DRG
Examples of immunocytochemical staining for FHFAs in primary cultured DRG neurons 
from control (sham operated, a) and induced local inflammation of the DRGs (LID, b) 
animals post-operative day 5. c, DRG neurons from LID animals (n=1989) exhibited an 
increase in FHFA signal relative to sham control (n=1116). Examples of 
immunocytochemical staining for FHF2B in primary cultured DRG neurons from control 
(sham operated, d) and induced local inflammation of the DRGs (LID, e) animals post-
operative day 5. f, DRG neurons from LID animals (n=1164) exhibited a decrease in FHF2B 
signal relative to sham control (n=1121). Five animals per group were examined. Asterisks 
(*) represent p <0.0001 obtained from Student’s t-test. Summary data are mean ± SEM. 
Scale bar 50 μm.
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Fig. 8. FHFA peptide reduces excitability of DRG neurons
a-b, No spontaneous activity (-SA) was detected on DRG neurons from sham rats when 1 
mM FHFA (n = 10) or 1 mM 5Q (n = 12) was included in the pipette solution. c-d, 30% of 
DRG neurons from local inflammation of the DRGs (LID) rats showed spontaneous activity 
(+SA) in the presence of 1 mM 5Q (n = 10), while no spontaneous activity was observed in 
the presence of 1 mM FHFA (n = 14). Representative action potential traces induced by a 2-s 
injection of 400 pA current on DRG neurons from sham (e) and LID (f) rats in the presence 
of 1 mM 5Q (left panel) or 1 mM FHFA (right panel). f and h, average number of action 
potentials induced by 2-s injection of currents ranging from 100 – 500 pA.
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